Vicor (VICR) insider trades 15,242 shares under 10b5-1 plan
Rhea-AI Filing Summary
Vicor Corporation (VICR) director Andrew D'Amico reported exercising options and selling the resulting shares. Across 10/22/2025–10/23/2025, he exercised and sold a total of 15,242 shares, with exercises at strike prices ranging from $25.30 to $75.43 and sales at prices from $80 to $90. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
The derivative table lists multiple non‑qualified stock option exercises tied to underlying common shares, with footnoted terms stating options expire 2 years from each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 15,242 shares ($630K approx. pre-tax spread)
Exercise and Sale
33 txns
Insider
D'Amico Andrew
Role
Director
Sold
15,242 shs ($1.26M)
Approx. gross sale proceeds
$1.26M
Approx. exercise cost
$633K
Approx. pre-tax spread
$630K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 565 | $0.00 | $0.00 |
| Exercise | Common Stock | 565 | $75.43 | $43K |
| Sale | Common Stock | 565 | $90.00 | $51K |
| Exercise | Non Qualified Stock Option | 4,500 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 3,100 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 565 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 1,600 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 995 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 3,917 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,500 | $25.30 | $89K |
| Sale | Common Stock | 3,500 | $80.00 | $280K |
| Exercise | Common Stock | 1,000 | $25.30 | $25K |
| Sale | Common Stock | 1,000 | $82.00 | $82K |
| Exercise | Common Stock | 1,000 | $36.60 | $37K |
| Sale | Common Stock | 1,000 | $84.00 | $84K |
| Exercise | Common Stock | 1,000 | $36.60 | $37K |
| Sale | Common Stock | 1,000 | $86.00 | $86K |
| Exercise | Common Stock | 1,100 | $36.60 | $40K |
| Sale | Common Stock | 1,100 | $88.00 | $97K |
| Exercise | Common Stock | 565 | $75.43 | $43K |
| Sale | Common Stock | 565 | $85.00 | $48K |
| Exercise | Common Stock | 1,600 | $60.61 | $97K |
| Sale | Common Stock | 1,600 | $80.00 | $128K |
| Exercise | Common Stock | 332 | $60.37 | $20K |
| Sale | Common Stock | 332 | $84.00 | $28K |
| Exercise | Common Stock | 332 | $60.37 | $20K |
| Sale | Common Stock | 332 | $86.00 | $29K |
| Exercise | Common Stock | 331 | $60.37 | $20K |
| Sale | Common Stock | 331 | $88.00 | $29K |
| Exercise | Common Stock | 2,917 | $41.61 | $121K |
| Sale | Common Stock | 2,917 | $80.00 | $233K |
| Exercise | Common Stock | 1,000 | $41.61 | $42K |
| Sale | Common Stock | 1,000 | $87.50 | $88K |
Holdings After Transaction:
Non Qualified Stock Option — 12,492 shares (Direct);
Common Stock — 0 shares (Direct)
Footnotes (2)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- F2. Options expire 2 years from each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did VICR director Andrew D'Amico report on Form 4?
He exercised options and sold the resulting shares totaling 15,242 shares on 10/22/2025–10/23/2025.
Were the VICR stock sales under a 10b5-1 plan?
Yes. The sales were effected under a Rule 10b5-1 trading plan adopted on September 12, 2024.
What were the option exercise prices in the VICR Form 4?
Exercises were at strike prices including $25.30, $36.60, $41.61, $60.37, $60.61, and $75.43.
What type of derivatives did the insider exercise?
Multiple non‑qualified stock options, each tied to underlying VICR common shares.
What is the option expiration term noted?
Footnote states options expire 2 years from each vesting date.
What is Andrew D'Amico’s relationship to VICR?
He is a Director, as indicated in the filing.